{"title":"杜拉鲁肽用于有效的糖尿病管理","authors":"C. Khan","doi":"10.15761/DU.1000123","DOIUrl":null,"url":null,"abstract":"The clinical and practical consideration of GLP1RAs has risen incredibly to treat T2DM since the development of Dulaglutide- a once-weekly formulation with the combined positive effects on both glucose control and weight management, along with the potential reduction in cardio-renal outcomes.","PeriodicalId":309709,"journal":{"name":"Diabetes Updates","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Dulaglutide For effective diabetes management\",\"authors\":\"C. Khan\",\"doi\":\"10.15761/DU.1000123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The clinical and practical consideration of GLP1RAs has risen incredibly to treat T2DM since the development of Dulaglutide- a once-weekly formulation with the combined positive effects on both glucose control and weight management, along with the potential reduction in cardio-renal outcomes.\",\"PeriodicalId\":309709,\"journal\":{\"name\":\"Diabetes Updates\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes Updates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/DU.1000123\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes Updates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/DU.1000123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The clinical and practical consideration of GLP1RAs has risen incredibly to treat T2DM since the development of Dulaglutide- a once-weekly formulation with the combined positive effects on both glucose control and weight management, along with the potential reduction in cardio-renal outcomes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
